6-[[2-amino-3-[[1-[(1-carboxy-2-sulfanylethyl)amino]-1-oxopropan-2-yl]amino]-3-oxopropyl]amino]-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-oxohexanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 6-[[2-amino-3-[[1-[(1-carboxy-2-sulfanylethyl)amino]-1-oxopropan-2-yl]amino]-3-oxopropyl]amino]-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-oxohexanoic acid
• 化学式: C₂₉H₃₇N₁₁O₉S
• 分子量: 715.7
• InChiKey: WXRMMBMIURAJGK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -7.8
• 重原子数：
  50
• 可旋转键数：
  19
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  323
• 氢给体数：
  11
• 氢受体数：
  15

文献信息

• TUBULYSIN CONJUGATE FOR USE IN TREATING CANCER
  申请人：ENDOCYTE, INC.

  公开号：US20170348376A1

  公开（公告）日：2017-12-07

  The invention described herein pertains to drug delivery conjugates for targeted therapy. The invention described herein relates to methods of treating folate receptor-expressing cancers with a folate-tubulysin conjugate. The invention described herein also relates to methods of treating folate-expressing cancers with a folate tubulysin conjugate in patients where stable disease results after treatment with the folate-tubulysin conjugate.

  本发明涉及用于靶向治疗的药物传递共轭物。本发明涉及使用叶酸-管芽霉素共轭物治疗表达叶酸受体的癌症的方法。本发明还涉及在使用叶酸-管芽霉素共轭物治疗后导致稳定疾病的患者中治疗表达叶酸的癌症的方法。
• US20140271468A1
  申请人：——

  公开号：US20140271468A1

  公开（公告）日：2014-09-18
• METHODS OF TREATING CANCER WITH TUBULYSIN CONJUGATES
  申请人：Endocyte, Inc.

  公开号：US20170290878A1

  公开（公告）日：2017-10-12

  The invention described herein pertains to drug delivery conjugates for targeted therapy. The invention described herein relates to methods of treating folate receptor-expressing cancers with a folate-tubulysin conjugate. The invention described herein also relates to methods of treating folate-expressing cancers with a folate tubulysin conjugate in patients where stable disease results after treatment with the folate-tubulysin conjugate.